ValiRx Plc (LON:VAL) shares were down 0% on Tuesday . The stock traded as low as GBX 3.08 ($0.04) and last traded at GBX 3.38 ($0.05). Approximately 5,676,848 shares changed hands during mid-day trading, an increase of 49% from the average daily volume of 3,820,000 shares. The stock had previously closed at GBX 3.38 ($0.05).
Separately, Beaufort Securities reaffirmed a “speculative buy” rating on shares of ValiRx in a report on Tuesday, December 19th.
The company has a market cap of $17.67 and a price-to-earnings ratio of -56.25.
TRADEMARK VIOLATION WARNING: This story was first posted by Stock Observer and is the sole property of of Stock Observer. If you are reading this story on another site, it was stolen and reposted in violation of United States and international trademark & copyright law. The original version of this story can be viewed at https://www.thestockobserver.com/2018/03/20/valirx-val-stock-price-down-0.html.
ValiRx Company Profile
ValiRx plc is a biopharmaceutical company. The principal activity of the Company is the development of oncology therapeutics and companion diagnostics. It focuses on the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. It operates in two business segments: drug development and the sale of self-test drug kits.
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.